Ruxolitinib Treatment in Inclusion Body Myositis

Clinical trial NCT06536166 · RECRUITING

Trial details

NCT number: NCT06536166
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Inclusion Body Myositis, Sporadic

Start date: 2025-05-27
Primary completion: 2028-06-10
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.